Autres langues Cerus Corporation

Actions

CERS

US1570851014

Equipement, fournitures et distribution médicale

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 31/07/2026			Varia. 5j.	Varia. 1 janv.
2,150 ^USD	-25,61%		-26,62%	+4,37%

31/07	Transcript : Cerus Corporation, Q2 2026 Earnings Call, Jul 30, 2026
30/07	Cerus Corporation révise ses prévisions de résultats pour l'exercice 2026	CI

Autres langues

30/07	Cerus: Q2 Earnings Snapshot
30/07	Cerus Corporation Announces Second Quarter 2026 Financial Results
30/07	Cerus Corporation Revises Earnings Guidance for the Year 2026
30/07	Cerus Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026
16/07	Cerus Corporation to Release Second Quarter 2026 Financial Results on July 30, 2026
22/06	Cerus Corporation(NasdaqGM:CERS) added to S&P Healthcare Equipment Select Industry Index
17/06	Cerus to Showcase New Evidence, Innovation and Global Experience with the INTERCEPT Blood System at the 39th International ISBT Congress
08/06	Cerus Corporation Enters into Second Amended and Restated Credit, Security and Guaranty Agreements for Term Loan and Revolving Loan Credit Facilities
08/06	Cerus Corporation Closes New Debt Facility of Up to $110 Million
08/06	Cerus Corporation Closes New Debt Facility of Up to $110 Million
03/06	Declaration of Voting Results by Cerus Corporation
27/05	Bradley L. Radoff Announces Intent to Withhold Votes for Cerus Corporation?s Directors
30/04	Cerus: Q1 Earnings Snapshot
30/04	Cerus Corporation Announces First Quarter 2026 Financial Results
30/04	Cerus Corporation Raises Product Revenue Guidance for the Full Year 2026
30/04	Cerus Corporation Reports Earnings Results for the First Quarter Ended March 31, 2026
27/04	Cerus Signs Supply Agreement With French Blood Establishment for Intercept System
27/04	Cerus Corporation Announces New, Four-Year Supply Agreement with French Blood Establishment for INTERCEPT Blood System
27/04	Cerus Corporation Signs Four-Year Supply Agreement With Établissement Français Du Sang
23/04	Cerus : Audit Committee Charter(Revised March 2026)
16/04	Cerus Corporation to Release First Quarter 2026 Financial Results on April 30, 2026
16/03	Cerus Names Vivek Jayaraman as President, CEO
16/03	Cerus appoints Vivek Jayaraman as president and chief executive officer
16/03	Cerus Appoints Vivek Jayaraman as President and Chief Executive Officer
16/03	Cerus Corporation Announces Chief Executive Officer Changes, Effective July 1, 2026